Evolución del intervalo QTc en pacientes con infección SARS-CoV-2 tratados con fármacos antivirales()

INTRODUCTION: Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. PATIENTS AND METHODS: Pediatric patients affected from COVID-19 who received antivirals w...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmel-Vilomara, Roger, Dolader, Paola, Sabaté-Rotes, Anna, Soriano-Arandes, Antoni, Gran, Ferran, Rosés-Noguer, Ferran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Asociación Española de Pediatría. 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057733/
https://www.ncbi.nlm.nih.gov/pubmed/33995537
http://dx.doi.org/10.1016/j.anpedi.2021.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057733/
https://www.ncbi.nlm.nih.gov/pubmed/33995537
http://dx.doi.org/10.1016/j.anpedi.2021.04.009

Ejemplares similares